This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by PARRY, L. J. Articles by SUMMERLEE, A. J. S. Search for Related Content PubMed PubMed Citation Articles by PARRY, L. J. Articles by SUMMERLEE, A. J. S.

Central Angiotensin Partially Mediates the Pressor Action of Relaxin in Anesthetized Rats^*

Biomedical Sciences, Ontario Veterinary College, University of Guelph Guelph, Ontario, NIG 2W1, Canada

Address all correspondence and requests for reprints to: L. J. Parry, Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, NlG 2W1, Canada.

Abstract

Experiments were conducted to investigate the role of the brain angiotensin system in mediating the pressor effects of porcine relaxin in anesthetized female rats. Continuous intracerebroventricular infusion of a specific angiotensin II receptor antagonist (Sar¹-Ala⁸-angiotensin II) completely negated the pressor response to centrally administered relaxin, but only partially suppressed the increase in blood pressure observed after iv injection of the hormone. These results indicate that the pressor effects of relaxin may be mediated, at least in part, by brain angiotensin. Rats with a compromised central angiotensin system were then treated in combination with a peripheral vasopressin (VI) receptor antagonist. Only after both treatments were the pressor effects of iv relaxin completely negated. These data imply that there is also a significant pressor action of relaxin which is independent of the brain angiotensin system. The most likely alternative is a direct action of relaxin on the neural lobe of the pituitary, to provoke the release of vasopressin.

Footnotes

^* This work was supported NSERC Canada and OMAF.

Received December 17, 1990.

This article has been cited by other articles:

				O. D. Sherwood Relaxin's Physiological Roles and Other Diverse Actions Endocr. Rev., April 1, 2004; 25(2): 205 - 234. [Abstract] [Full Text] [PDF]

				P. Sinnayah, P. Burns, J. D. Wade, R. S. Weisinger, and M. J. McKinley Water Drinking in Rats Resulting from Intravenous Relaxin and Its Modification by Other Dipsogenic Factors Endocrinology, November 1, 1999; 140(11): 5082 - 5086. [Abstract] [Full Text]

				A. J. S. Summerlee, D. J. Hornsby, and D. G. Ramsey The Dipsogenic Effects of Rat Relaxin: The Effect of Photoperiod and the Potential Role of Relaxin on Drinking in Pregnancy Endocrinology, May 1, 1998; 139(5): 2322 - 2328. [Abstract] [Full Text] [PDF]

				A. J. S. Summerlee, D. G. Ramsey, and R. S. Poterski Neutralization of Relaxin within the Brain Affects the Timing of Birth in Rats Endocrinology, February 1, 1998; 139(2): 479 - 484. [Abstract] [Full Text] [PDF]